Angiotensin II receptor antagonists

Details for Australian Patent Application No. 2007334521 (hide)

Owner Merck & Co., Inc.

Inventors Nargund, Ravi P.; Lo, Michael Man-Chu; Sebhat, Iyassu K.; Ali, Amjad

Agent Peter Maxwell & Associates

Pub. Number AU-B-2007334521 (Modified Examination)

PCT Pub. Number WO2008/076245

Priority 60/874,631 13.12.06 US

Filing date 11 December 2007

Wipo publication date 26 June 2008

Acceptance publication date 29 March 2012

International Classifications

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/076245 Priority application(s): WO2008/076245

20 October 2011 Amendment Made

  The nature of the amendment is: Amend the invention title to read Angiotensin II receptor antagonists 2008

29 March 2012 Application Accepted

  Published as AU-B-2007334521 (Modified Examination)

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007334522-Angiotensin II receptor antagonists

2007334519-Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment